F.D.A. Rejects Savient’s Gout Drug
Monday, August 3, 2009 - 09:56
in Health & Medicine
The maker of Krystexxa said regulators were concerned about changes to the manufacturing process.
The maker of Krystexxa said regulators were concerned about changes to the manufacturing process.